Sunshine Heart Inc  

(Public, ASX:SHC)   Watch this stock  
Find more results for SHC
0.0000
Delayed:  
ASX data delayed by 20 mins - Disclaimer
Currency in
Range     -
52 week 0.02 - 0.06
Open     -
Vol. 0.00
Mkt cap     -
P/E     -
Div/yield     -
EPS -1.81
Shares     -
Beta     -
Inst. own     -
Nov 2, 2016
Q3 2016 Sunshine Heart Inc Earnings Release (Estimated) - 12:30AM GMT+11 - Add to calendar
Aug 25, 2016
Sunshine Heart Inc at CFA Society of Minnesota's InvestMNt Conference
Aug 9, 2016
Q2 2016 Sunshine Heart Inc Earnings Release
Aug 9, 2016
Q2 2016 Sunshine Heart Inc Earnings Call
  

Key stats and ratios

Q2 (Jun '16) 2015
Net profit margin - -45055.93%
Operating margin - -43996.61%
EBITD margin - -43445.76%
Return on average assets -109.17% -93.37%
Return on average equity -297.28% -128.46%
Employees 37 -
CDP Score - -

Address

12988 Valley View Rd
EDEN PRAIRIE, MN 55344-3657
United States - Map
+1-952-3454200 (Phone)
+1-302-6365454 (Fax)

Website links

Description

Sunshine Heart, Inc. is a medical device company. The Company operates through cardiac and coronary disease products segment. The Company is focused on developing, manufacturing and commercializing its C-Pulse Heart Assist System (the C-Pulse System) for treatment of Class III and ambulatory Class IV heart failure. The C-Pulse System is based on the concept of counterpulsation applied in an extra-aortic approach to assist the left ventricle by reducing the workload required to pump blood throughout the body, while increasing blood flow to the coronary arteries. Once implanted, the C-Pulse cuff is positioned around the patient's ascending aorta above the aortic valve. An electrocardiogram sensing lead is then attached to the heart to determine timing for cuff inflation and deflation in synchronization with the heartbeat.

Officers and directors

John L. Erb Chairman of the Board, President, Chief Executive Officer
Age: 67
Claudia Drayton Chief Financial Officer, Secretary
Age: 47
Debra J. Kridner Executive Vice President - Clinical Research & Regulatory Affairs
Age: 63
Brian Brown Senior Vice President - Operations and Technology
Age: 54
Molly Wade Vice President, Worldwide Patient Recruitment and Marketing
Age: 37
Megan Brandt Vice President - Regulatory Affairs and Quality Assurance
Paul R. Buckman Lead Independent Director
Age: 60
Jon W. Salveson Independent Director
Age: 50
Gregory D. Waller Independent Director
Age: 66
Warren S. Watson Independent Director
Age: 63